Search Within

Michael Andrew Curran

Formats
  1. Journal Article (9)
  2. Meeting Abstract (6)
Groups
  1. Melanoma Disease Management Team (9)
  2. Department of Medicine (5)
  3. GSK Faculty (5)
  4. Center for Hematologic Malignancies (4)
  5. Melanoma and Immunotherapeutics Service (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. James Allison (10)
  2. Jedd Wolchok (3)
  3. Margaret Callahan (3)
  4. Welby Montalvo Ortiz (3)
  5. Alexander Lesokhin (2)
  6. Charlotte Ariyan (2)

More People

Years
  1. 2019 (1)
  2. 2013 (2)
  3. 2012 (4)
  4. 2011 (1)
  5. 2010 (2)
  6. 2009 (2)

More Years

Publications
  1. Cancer Research (3)
  2. Journal of Clinical Oncology (2)
  3. PLoS ONE (2)
  4. Cell Transplantation (1)
  5. Immunobiology (1)
  6. Journal for ImmunoTherapy of Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (2)
  3. Public Library of Science (2)
  4. American Society for Clinical Investigation (1)
  5. Biomed Central Ltd (1)
  6. Cognizant Communication Corporation (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Blocking LILRB and KIR receptors by B57 open conformers induces potent antitumor activity and acts synergistically with checkpoint blockade inhibition
    Meeting Abstract

    Renner, C.; Curran, M. A.; Kolibaba, J.; Liu, Y.; Petrausch, U.; Zippelius, A.; Stenner, F.; Rafiei, A.; Belaunzaran, O. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Peripheral and tumor immune correlates in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model
    Journal Article

    Mineharu, Y.; Muhammad, A. G.; Yagiz, K.; Candolfi, M.; Kroeger, K. M.; Xiong, W.; Puntel, M.; Liu, C.; Levy, E.; Lugo, C.; more...
    Neurotherapeutics (2012)

    Fulltext@MSK | Save
  • Systemic 4-1BB activation induces a novel T-cell phenotype driven by high expression of Eomesodermin
    Meeting Abstract

    Curran, M.; Geiger, T.; Montalvo, W.; Kim, M.; Reiner, S.; Al Shamkhani, A.; Sun, J.; Allison, J.
    Journal of Immunology (2012)

    Fulltext@MSK | Save
  • Response to "Ipilimumab (Yervoy) and the TGN1412 catastrophe"
    Journal Article

    Curran, M. A.; Callahan, M. K.; Subudhi, S. K.; Allison, J. P.
    Immunobiology (2012)

    Fulltext@MSK | Save
  • Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer
    Journal Article

    Jenq, R. R.; Curran, M. A.; Goldberg, G. L.; Liu, C.; Allison, J. P.; van den Brink, M. R. M.
    PLoS ONE (2012)

    Fulltext@MSK | Save
  • Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production
    Journal Article

    Curran, M. A.; Kim, M.; Montalvo, W.; Al Shamkhani, A.; Allison, J. P.
    PLoS ONE (2011)

    Fulltext@MSK | Save
  • 4-1BB activation induces the master-regulator eomes and a broad-spectrum TH1 phenotype which synergizes with CTLA-4 blockade to reject B16 melanoma
    Meeting Abstract

    Curran, M. A.; Kim, M. J.; Al Shamkhani, A.; Allison, J. P.
    Journal of Immunotherapy (2010)

    Fulltext@MSK | Save
  • PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
    Journal Article

    Curran, M. A.; Montalvo, W.; Yagita, H.; Allison, J. P.
    Proceedings of the National Academy of Sciences of the United States of America (2010)

    Fulltext@MSK | Save